Annual Lung SPORE Workshop (Abstract Submission): Submission #71

Submission information
Submission Number: 71
Submission ID: 110632
Submission UUID: d9ac044b-24ca-4fd2-a7aa-f1b15d8c7e17

Created: Mon, 03/11/2024 - 14:54
Completed: Mon, 03/11/2024 - 14:58
Changed: Thu, 05/09/2024 - 11:48

Remote IP address: 10.208.24.212
Submitted by: Anonymous
Language: English

Is draft: No
Michael
Grant
2033147088
Yale University
Efficacy of afatinib in patients with tumors harboring the uncommon EGFR exon 19 deletion, L747_A750delinsP: a pooled analysis
First Author
Michael
Grant
Yale University
Additional Authors
  • First Name: Fernando
    Last Name: de Miguel
    Affiliation: Yale University
  • First Name: Michael
    Last Name: Kane
    Affiliation: Yale University
  • First Name: Yong
    Last Name: Kong
    Affiliation: Yale University
  • First Name: Jieling
    Last Name: Miao
    Affiliation: Fred Hutchinson Cancer Research Center
  • First Name: Mary
    Last Name: Redman
    Affiliation: Fred Hutchinson Cancer Research Center
  • First Name: Zenta
    Last Name: Walther
    Affiliation: Yale University
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Yale University
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale University
Session 1: Oncogene-driven lung cancers and resistance to targeted therapies
No
Approved to be a Poster Presenter
{Empty}
Poster Submission
{Empty}